全文获取类型
收费全文 | 234588篇 |
免费 | 21068篇 |
国内免费 | 13879篇 |
专业分类
耳鼻咽喉 | 2164篇 |
儿科学 | 2987篇 |
妇产科学 | 4872篇 |
基础医学 | 27938篇 |
口腔科学 | 4198篇 |
临床医学 | 29506篇 |
内科学 | 37587篇 |
皮肤病学 | 2790篇 |
神经病学 | 13219篇 |
特种医学 | 8469篇 |
外国民族医学 | 96篇 |
外科学 | 26075篇 |
综合类 | 33760篇 |
现状与发展 | 48篇 |
一般理论 | 45篇 |
预防医学 | 14333篇 |
眼科学 | 6585篇 |
药学 | 23783篇 |
157篇 | |
中国医学 | 10851篇 |
肿瘤学 | 20072篇 |
出版年
2024年 | 227篇 |
2023年 | 3081篇 |
2022年 | 4636篇 |
2021年 | 9869篇 |
2020年 | 8293篇 |
2019年 | 7520篇 |
2018年 | 7970篇 |
2017年 | 6954篇 |
2016年 | 6643篇 |
2015年 | 10061篇 |
2014年 | 12675篇 |
2013年 | 11869篇 |
2012年 | 17527篇 |
2011年 | 19203篇 |
2010年 | 11691篇 |
2009年 | 9365篇 |
2008年 | 12748篇 |
2007年 | 12796篇 |
2006年 | 12352篇 |
2005年 | 12432篇 |
2004年 | 8591篇 |
2003年 | 7628篇 |
2002年 | 6585篇 |
2001年 | 5962篇 |
2000年 | 6079篇 |
1999年 | 6362篇 |
1998年 | 3551篇 |
1997年 | 3566篇 |
1996年 | 2706篇 |
1995年 | 2580篇 |
1994年 | 2228篇 |
1993年 | 1492篇 |
1992年 | 2285篇 |
1991年 | 1996篇 |
1990年 | 1664篇 |
1989年 | 1454篇 |
1988年 | 1263篇 |
1987年 | 1151篇 |
1986年 | 933篇 |
1985年 | 748篇 |
1984年 | 491篇 |
1983年 | 380篇 |
1982年 | 224篇 |
1981年 | 201篇 |
1980年 | 191篇 |
1979年 | 243篇 |
1978年 | 141篇 |
1977年 | 112篇 |
1976年 | 97篇 |
1974年 | 116篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Yunbao Xu Mengting Zhang Jiaying Zhang Derry Minyao Ng Xiaoxiao Chen Yuexiu Si Yetan Shi Xiangyuan Li Danyi Mao Lu Yang 《Taiwanese journal of obstetrics & gynecology》2021,60(3):433-441
Cervical cancer is a global health challenge in women. Neoadjuvant chemotherapy (NACT) is a recent prospect for alternative cervical cancer treatments. This study investigated the efficacy of NACT against resectable cervical cancer based on the medium and long-term survival of patients with the disease. We searched through PubMed, Web of Science, EBSCO and Cochrane Library for relevant reports published by June 2020. The primary outcomes were 3-year and 5-year progression-free survival (PFS) and overall survival (OS) of patients with resectable cervical cancer. Overall, 22 publications encompassing 5627 patients fulfilled the inclusion criteria. We found NACT not to affect both 3-year PFS and OS as well as 5-year PFS of patients with resectable cervical cancer. However, NACT significantly improves the 5-year OS of patients with resectable cervical cancer (HR = 0.83, 95% CI: 0.73–0.94, p = 0.013). Subgroup analysis (RCTs, non-RCTs, NACT + surgery + AT vs. surgery + AT, NACT + surgery + AT vs. CCRT/RT/CRT) further revealed NACT had no significant effect on 5-year PFS of patients with resectable cervical cancer, converse to the 5-year OS subgroup analysis, which validated the beneficial effect of NACT in patients with resectable cervical cancer. In addition, the effect of NACT was most significant in the non-RCTs subgroup (p = 0.012). NACT may improve the long-term prognosis of patients with resectable cervical cancer. However, further large-scale multicenter studies are needed to validate this finding. 相似文献
42.
Tian-Chi Tsai Huan-Ka Chiung Liang-Hsuan Chen Hsien-Ming Wu 《Taiwanese journal of obstetrics & gynecology》2021,60(3):567-569
ObjectiveAssisted oocyte activation combined with ICSI (ICSI-AOA) has been reported to improve fertilization outcomes of couples with oocyte activation deficiency (OAD). Although there's no sufficient evidence to support ICSI-AOA as routine use, it might be beneficial for POSEIDON group 3 patients with suspected oocyte-related OAD.Case reportA 29-year-old female presented with a history of primary infertility for two years. She was classified as a POSEIDON group 3 patient and had a total fertilization failure history. With the help of ICSI-AOA, six oocytes were successfully fertilized. Pregnancy was later confirmed after embryo transfer. A living infant was born after 34 weeks of pregnancy.ConclusionOAD should be taken into consideration for POSEIDON group 3 patients since low Antimüllerian hormone is associated decreased quality. Further research needs to be done to understand the mechanism underlying oocyte-related OAD and the potential role of ICSI-AOA in young patients with suboptimal ovarian response. 相似文献
43.
目的 发现四物汤的新药理作用并辨识其有效成分群。方法 于GEO和Cmap数据库获取四物汤和1309个小分子药物的基因表达谱,计算差异表达基因及四物汤与1309个小分子药物的基因表达谱间的相似性,相似性较高的小分子药物的药理作用为四物汤的新药理作用。相似性较高的小分子药物的靶点作为四物汤发挥新药理作用的靶标,利用分子对接技术辨识四物汤的有效成分群。结果 四物汤具有抗乳腺癌的作用,其有效成分群为荭草苷、芍药苷和半乳糖醛酸等,并通过文献调研验证了辨识结果的可靠性。结论 本研究将为扩大四物汤的临床应用范围及质量控制奠定基础,为乳腺癌的治疗提供新方法。 相似文献
44.
目的 探讨经颅直流电刺激(tDCS)对精神分裂症伴迟发性运动障碍(TD)患者空间工作记
忆的影响。方法 选取2017 年6 月至2018 年1 月来源于苏州市广济医院、苏州市社会福利总院、太仓市
精神卫生中心、南充市第六人民医院四家精神专科医院的38 例住院精神分裂症伴TD 患者,随机分为试
验组(21 例)和对照组(17 例)。研究期间,两组患者均接受常规药物治疗,试验组予以tDCS 治疗,采用的
电流为2 mA,刺激部位为左侧背外侧前额叶皮质及对侧眶上缘;对照组相应地予以伪tDCS 治疗。在基
线期、治疗15 次结束后及2 周后进行随访,采用剑桥神经心理自动化成套测试(CANTAB)中的空间工作
记忆(SWM)模块分别对两组患者进行认知测评。结果 在完成15 次治疗后,试验组SWM 指标分析中
的总错误数[31.00(28.50,49.00)]、平均第一次响应时间(4 盒子)[3 289.500(1 871.750,5 018.000)ms]、
平均第一次响应时间(6 盒子)[2 862.500(2 128.500,4 672.250)ms]、平均第一次响应时间(8 盒子)
[3 328.500(2 611.250,5 120.750)ms]与对照组比较,差异无统计学意义(P> 0.05);试验组SWM 指标分
析中的策略分[19.00(17.00,20.00)]低于对照组[21.00(19.50,23.00)],差异有统计学意义(P < 0.05)。
在2 周后的随访中,两组的SWM 各指标比较,差异均无统计学意义(P> 0.05)。结论 tDCS 可能对精神
分裂症患者使用策略的能力有即刻改善效应。 相似文献
45.
Melanie A. Krook Julie W. Reeser Gabrielle Ernst Hannah Barker Max Wilberding Gary Li Hui-Zi Chen Sameek Roychowdhury 《British journal of cancer》2021,124(5):880
Fibroblast growth factor receptors (FGFRs) are aberrantly activated through single-nucleotide variants, gene fusions and copy number amplifications in 5–10% of all human cancers, although this frequency increases to 10–30% in urothelial carcinoma and intrahepatic cholangiocarcinoma. We begin this review by highlighting the diversity of FGFR genomic alterations identified in human cancers and the current challenges associated with the development of clinical-grade molecular diagnostic tests to accurately detect these alterations in the tissue and blood of patients. The past decade has seen significant advancements in the development of FGFR-targeted therapies, which include selective, non-selective and covalent small-molecule inhibitors, as well as monoclonal antibodies against the receptors. We describe the expanding landscape of anti-FGFR therapies that are being assessed in early phase and randomised controlled clinical trials, such as erdafitinib and pemigatinib, which are approved by the Food and Drug Administration for the treatment of FGFR3-mutated urothelial carcinoma and FGFR2-fusion cholangiocarcinoma, respectively. However, despite initial sensitivity to FGFR inhibition, acquired drug resistance leading to cancer progression develops in most patients. This phenomenon underscores the need to clearly delineate tumour-intrinsic and tumour-extrinsic mechanisms of resistance to facilitate the development of second-generation FGFR inhibitors and novel treatment strategies beyond progression on targeted therapy.Subject terms: Cancer, Cancer 相似文献
46.
Her-Shyong Shiah Nai-Jung Chiang Chia-Chi Lin Chia-Jui Yen Hui-Jen Tsai Shang-Yin Wu Wu-Chou Su Kwang-Yu Chang Ching-Chiung Wang Jang-Yang Chang Li-Tzong Chen 《The oncologist》2021,26(4):e567-e579
Lessons Learned
- SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
- This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
- SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
47.
“三全育人”视角下思政教育机制实践与探索——“杏林成长导师”计划的构建 《医学教育管理》2021,7(6):656-660
“三全育人”是高校思政教育工作的关键一环,也是中医药高校推动思政教育的重要内容。以“三全育人”为视角对北京中医药大学思想政治教育举措“杏林成长导师”计划路径、内容深入分析,运用统计分析和文献研究方法,剖析该计划对中医学专业大学生的学业、思想和实践等多个层面的现实成效,从而为“三全育人”理念在中医药院校制度建构中的应用提供新的视角与方法。 相似文献
48.
Zongzhang Huang Qigu Yao Jianping Zhu Ying He Yanghao Chen Feng Wu Teng Hua 《Diagnostic and interventional imaging》2021,102(5):279-285
PurposeThe purpose of this study was to make a systematic review and meta-analysis to determine the stent diameter (8 mm vs. 10 mm) that conveys better safety and clinical efficacy for transjugular intrahepatic portosystemic shunt (TIPS).Materials and methodsFour databases were used to identify clinical trials published from inception until March 2020. Data were extracted to estimate and compare one-year and three-year overall survivals, hepatic encephalopathy, variceal rebleeding, and shunt dysfunction rates between patients with 8 mm covered stents and those with 10 mm covered stents.ResultsFive eligible studies were selected, which included 489 patients (316 men, 173 women). The 8 mm covered stent group had higher efficacy regarding one-year or three-year overall survival (odds ratio [OR], 2.88; P = 0.003) and (OR, 1.81; P = 0.04) and lower hepatic encephalopathy (OR, 0.69; P = 0.04) compared with 10 mm covered stent group. There were no significant differences in variceal rebleeding rate (OR 0.80; P = 0.67). However, shunt dysfunction was lower in 10 mm covered stent group (OR, 2.26; P = 0.003).ConclusionsOur results suggest that the use of 8 mm covered stents should be preferred to that of 10 mm covered stents for TIPS placement when portal pressure is frequently monitored. 相似文献
49.
目的 探究七方胃痛颗粒对转化生长因子-β1(TGF-β1)诱导人胃腺癌细胞AGS上皮间质转化(Epithelial-mesenchymal transition, EMT)过程的影响及其潜在分子机制。方法 为了探究七方胃痛颗粒对TGF-β1处理的AGS细胞增殖、迁移和侵袭的影响,实验分为四组:AGS细胞对照组,EMT空白模型组,中药血清组,TGF-β/smad通路抑制剂组,分别利用CCK8、细胞划痕实验和Transwell实验检测细胞增殖、迁移和侵袭能力。此外,通过免疫荧光检测EMT过程中相关蛋白(E-cadherin、N-cadherin、14-3-3ζ、Smad2和p-Smad2/3)的表达水平。结果 与AGS细胞对照组相比,TGF-β1诱导EMT过程,显著促进AGS细胞增殖、迁移和侵袭,下调了E-cadherin的表达,上调了N-cadherin、14-3-3ζ、Smad2和p-Smad2/3的表达;与EMT空白模型组相比,中药血清组、TGF-β/smad通路抑制剂组显著抑制了细胞增殖、迁移和侵袭,上调了E-cadherin的表达,降低了N-cadherin、14-3-3ζ、Smad2和p-Smad2/3的表达。结论 七方胃痛颗粒通过调控TGF-β/smad信号通路从而抑制人胃腺癌AGS细胞的EMT过程。 相似文献
50.